Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

TYRA

+ Watchlist+ Portfolio

Tyra Biosciences, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$19.61
52-Week Range
$16.86 – $40.65
Market Cap
$1.36B
P/E (TTM)
—
EPS (TTM)
-2.63
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.96
PEG Ratio
—
Return on Equity
-34.89%
Return on Assets
-22.15%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
23.93
Debt/Equity
0.01
Total Debt
$5.46M
Free Cash Flow
$-66.89M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$667.92M

Market Snapshot

About

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing precision medicines that target fibroblast growth factor receptors (FGFRs). The company is advancing a pipeline of selective FGFR inhibitors designed to treat patients with cancer and other serious diseases. Tyra utilizes its proprietary SNÃ…P platform to design highly selective kinase inhibitors.